{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:40:47Z","timestamp":1792816847908,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"publisher","award":["806\/20 S-EB"],"award-info":[{"award-number":["806\/20 S-EB"]}],"id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ijid.2021.06.066","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T11:16:42Z","timestamp":1625311002000},"page":"142-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Clinical and microbiological features and outcomes of mucormycosis in critically ill patients"],"prefix":"10.1016","volume":"109","author":[{"given":"Kathrin","family":"Rothe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krischan","family":"Braitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Okrojek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Heim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Rasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareike","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland M.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk H.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Lahmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.ijid.2021.06.066_bib0001","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 6","key":"10.1016\/j.ijid.2021.06.066_bib0002","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/1469-0691.12566","article-title":"Mucormycosis \u2013 from the pathogens to the disease","volume":"20","author":"Binder","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2021.06.066_bib0003","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2021.06.066_bib0004","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2021.06.066_bib0005","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ijantimicag.2011.11.017","article-title":"Invasive fungal infections in patients with cancer in the intensive care unit","volume":"39","author":"Sipsa","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2021.06.066_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179136","article-title":"Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: epidemiology and microbiological characterization of the isolates","volume":"12","author":"Guinea","year":"2017","journal-title":"PLoS One"},{"issue":"Suppl. 6","key":"10.1016\/j.ijid.2021.06.066_bib0007","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/1469-0691.12563","article-title":"Epidemiology of mucormycosis in Europe","volume":"20","author":"Petrikkos","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2021.06.066_bib0008","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s15010-017-0991-6","article-title":"Pulmonary mucormycosis: clinical features and outcomes","volume":"45","author":"Lin","year":"2017","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2021.06.066_bib0009","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40121-017-0183-9","article-title":"Challenges and solution of invasive aspergillosis in non-neutropenic patients: a review","volume":"7","author":"Bassetti","year":"2018","journal-title":"Infect Dis Ther"},{"issue":"911","key":"10.1016\/j.ijid.2021.06.066_bib0010","first-page":"1136","article-title":"A rare cause of gastrointestinal bleeding in the intensive care unit. Healthcare-associated mucormycosis","volume":"146","author":"Machicado","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijid.2021.06.066_bib0011","article-title":"A case report of cutaneous mucormycosis of the hand after minor trauma in a patient with acute myeloid leukaemia","volume":"23","author":"Maleitzke","year":"2019","journal-title":"Trauma Case Rep"},{"key":"10.1016\/j.ijid.2021.06.066_bib0012","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13613-020-00673-9","article-title":"Mucormycosis in intensive care unit: surgery is a major prognostic factor in patients with hematological malignancy","volume":"10","author":"Claustre","year":"2020","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ijid.2021.06.066_bib0013","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2021.06.066_bib0014","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.annemergmed.2004.11.021","article-title":"Reassessing the methods of medical record review studies in emergency medicine research","volume":"45","author":"Worster","year":"2005","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ijid.2021.06.066_bib0015","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0196-0644(96)70264-0","article-title":"Chart reviews in emergency medicine research: where are the methods?","volume":"27","author":"Gilbert","year":"1996","journal-title":"Ann Emerg Med"},{"issue":"Suppl. 1","key":"10.1016\/j.ijid.2021.06.066_bib0016","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 1","key":"10.1016\/j.ijid.2021.06.066_bib0017","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/cid\/cir880","article-title":"A global analysis of mucormycosis in France: the RetroZygo Study (2005\u20132007)","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2021.06.066_bib0018","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/jof6040265","article-title":"Epidemiology and diagnosis of mucormycosis: an update","volume":"6","author":"Skiada","year":"2020","journal-title":"J Fungi"},{"key":"10.1016\/j.ijid.2021.06.066_bib0019","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1128\/JCM.00256-11","article-title":"Molecular methods to improve diagnosis and identification of mucormycosis","volume":"49","author":"Hammond","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2021.06.066_bib0020","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1093\/cid\/ciy473","article-title":"Breakthrough invasive mold infections in the hematology patient: current concepts and future directions","volume":"67","author":"Lionakis","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2021.06.066_bib0021","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.3324\/haematol.2012.083063","article-title":"Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries","volume":"98","author":"Pagano","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.ijid.2021.06.066_bib0022","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/589857","article-title":"Combination polyene\u2013caspofungin treatment of rhino-orbital-cerebral mucormycosis","volume":"47","author":"Reed","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.ijid.2021.06.066_bib0023","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/mmy\/myx101","article-title":"Challenges in the diagnosis and treatment of mucormycosis","volume":"56","author":"Skiada","year":"2018","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijid.2021.06.066_bib0024","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cmi.2016.03.029","article-title":"Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis","volume":"22","author":"Kyvernitakis","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2021.06.066_bib0025","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2147\/DDDT.S145545","article-title":"Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy","volume":"12","author":"Jenks","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ijid.2021.06.066_bib0026","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case\u2013control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2021.06.066_bib0027","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s40265-016-0652-6","article-title":"Isavuconazole: a review in invasive aspergillosis and mucormycosis","volume":"76","author":"Shirley","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.ijid.2021.06.066_bib0028","doi-asserted-by":"crossref","first-page":"e00585","DOI":"10.1128\/AAC.00585-18","article-title":"Isavuconazole concentration in real-world practice: consistency with results from clinical trials","volume":"62","author":"Andes","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2021.06.066_bib0029","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01162-19","article-title":"Influence of sustained low-efficiency dialysis treatment on isavuconazole plasma levels in critically ill patients","volume":"63","author":"Lahmer","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2021.06.066_bib0030","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/562610","article-title":"Clinical features and outcome of mucormycosis","volume":"2014","author":"Camara-Lemarroy","year":"2014","journal-title":"Interdiscip Perspect Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221005555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221005555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:58:01Z","timestamp":1761119881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221005555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":30,"alternative-id":["S1201971221005555"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.06.066","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and microbiological features and outcomes of mucormycosis in critically ill patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.06.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}